Glenmark Pharmaceuticals logo

Glenmark Pharmaceuticals shareholders and shareholding pattern

NSE: GLENMARKBSE: 532296Pharmaceuticals & BiotechnologyMid Cap

Last close ₹2,166.60down ₹31.90 (1.45%)BSE ₹2,129.60

Share price at the NSE close on 23 Oct 2026. Previous close ₹2,198.50.

52-week range of traded prices to 23 Oct 2026
₹1,792.60Low, 28 Oct 2025₹2,537.60High, 28 Aug 2026
Market cap
₹61,147 Cr176th largest listed
P/E
34.0
P/E without one-offs
16.3
P/B
5.8
Dividend yield
0.12%
ROE
18.6%
ROE without one-offs
38.6%
ROCE
39.8%
Debt to equity
0.00
Volume, NSE
8,92,79752.3% delivered

Who owns Glenmark Pharmaceuticals, filing by filing

Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.

Sep 2026 filing

  • Promoters46.65%
  • Foreign institutions21.51%
  • Indian institutions17.64%
  • Governments0.04%
  • Individuals and others14.17%

Shareholding pattern, per cent, from Sep 2022

  • Promoters
  • Foreign institutions
  • Indian institutions
  • Governments
  • Individuals and others
Per centDec 2016Filed 12 JanMar 2017Filed 11 AprJun 2017Filed 17 JulSep 2017Filed 12 OctDec 2017Filed 17 JanMar 2018Filed 19 AprJun 2018Filed 17 JulSep 2018Filed 8 OctDec 2018Filed 18 JanMar 2019Filed 12 AprJun 2019Filed 16 JulSep 2019Filed 18 OctDec 2019Filed 9 JanMar 2020Filed 22 AprJun 2020Filed 20 JulSep 2020Filed 19 OctDec 2020Filed 20 JanMar 2021Filed 10 AprJun 2021Filed 12 JulSep 2021Filed 21 OctDec 2021Filed 19 JanMar 2022Filed 14 AprJun 2022Filed 18 JulSep 2022Filed 21 OctDec 2022Filed 20 JanMar 2023Filed 18 AprJun 2023Filed 19 JulSep 2023Filed 17 OctDec 2023Filed 11 JanMar 2024Filed 16 AprJun 2024Filed 18 JulSep 2024Filed 18 OctDec 2024Filed 20 JanMar 2025Filed 16 AprJun 2025Filed 18 JulSep 2025Filed 14 OctDec 2025Filed 13 JanMar 2026Filed 15 AprJun 2026Filed 16 JulSep 2026Filed 19 Oct
46.49%46.50%46.53%46.53%46.54%46.54%46.54%46.54%46.54%46.54%46.58%46.58%46.59%46.62%46.62%46.63%46.63%46.63%46.63%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.64%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%
Indian promoters46.49%46.50%46.53%46.53%46.54%46.54%46.54%46.54%46.54%46.54%46.58%46.58%46.59%46.62%46.62%46.63%46.63%46.63%46.63%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.64%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.65%
53.51%53.50%53.47%53.47%53.46%53.46%53.46%53.46%53.46%53.46%53.42%53.42%53.41%53.38%53.38%53.37%53.37%53.37%53.37%53.35%53.35%53.35%53.35%53.35%53.35%53.35%53.35%53.35%53.35%53.36%53.35%53.35%53.35%53.35%53.35%53.35%53.35%53.35%53.35%53.35%
Shares in issue28,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,68,15628,21,88,15628,21,88,15628,21,88,15628,21,88,15628,21,88,15628,22,00,80928,22,00,80928,22,00,80928,22,00,80928,22,00,80928,22,24,672
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.

Number of Glenmark Pharmaceuticals shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

ShareholdersDec 2016Filed 12 JanMar 2017Filed 11 AprJun 2017Filed 17 JulSep 2017Filed 12 OctDec 2017Filed 17 JanMar 2018Filed 19 AprJun 2018Filed 17 JulSep 2018Filed 8 OctDec 2018Filed 18 JanMar 2019Filed 12 AprJun 2019Filed 16 JulSep 2019Filed 18 OctDec 2019Filed 9 JanMar 2020Filed 22 AprJun 2020Filed 20 JulSep 2020Filed 19 OctDec 2020Filed 20 JanMar 2021Filed 10 AprJun 2021Filed 12 JulSep 2021Filed 21 OctDec 2021Filed 19 JanMar 2022Filed 14 AprJun 2022Filed 18 JulSep 2022Filed 21 OctDec 2022Filed 20 JanMar 2023Filed 18 AprJun 2023Filed 19 JulSep 2023Filed 17 OctDec 2023Filed 11 JanMar 2024Filed 16 AprJun 2024Filed 18 JulSep 2024Filed 18 OctDec 2024Filed 20 JanMar 2025Filed 16 AprJun 2025Filed 18 JulSep 2025Filed 14 OctDec 2025Filed 13 JanMar 2026Filed 15 AprJun 2026Filed 16 JulSep 2026Filed 19 Oct
All shareholders85,47588,1031,28,5471,36,6761,54,7991,53,5071,45,9521,30,9251,23,8851,20,4301,24,2591,29,8601,37,4181,54,6253,24,3782,63,0602,36,7302,50,8512,75,8013,29,8703,17,3833,10,5163,12,4733,13,5403,00,1062,85,4612,36,9082,32,6852,09,9311,99,4511,92,6301,93,9491,95,0591,92,7241,90,2101,98,7892,01,5841,96,1052,11,4182,08,414
6666666666666666666666666666666666666666
Indian promoters6666666666666666666666666666666666666666
85,46988,0971,28,5411,36,6701,54,7931,53,5011,45,9461,30,9191,23,8791,20,4241,24,2531,29,8541,37,4121,54,6193,24,3722,63,0542,36,7242,50,8452,75,7953,29,8643,17,3773,10,5103,12,4673,13,5343,00,1002,85,4552,36,9022,32,6792,09,9251,99,4451,92,6241,93,9431,95,0531,92,7181,90,2041,98,7832,01,5781,96,0992,11,4122,08,408
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Glenmark Pharmaceuticals promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is SALDANHA FAMILY TRUST, 45.44%.Promoter buying and selling

Holder
SALDANHA FAMILY TRUSTIndian companies, trusts and others45.44%12,82,41,936
BLANCHE ELIZABETH SALDANHAIndividuals and Hindu undivided families0.39%11,14,327
GLENN MARIO SALDANHAIndividuals and Hindu undivided families0.36%10,11,644
CHERYLANN MARIA PINTOIndividuals and Hindu undivided families0.27%7,63,915
ROBIN JOSEPH PINTOIndividuals and Hindu undivided families0.18%4,99,500
NEHA SALDANHAIndividuals and Hindu undivided families0.01%26,000
No promoter shares are reported as pledged.

Largest public holders of Glenmark Pharmaceuticals, filing by filing

Per cent, on the same shares as the split above.Mutual funds holding Glenmark Pharmaceuticals

HolderDec 2016Filed 12 JanMar 2017Filed 11 AprJun 2017Filed 17 JulSep 2017Filed 12 OctDec 2017Filed 17 JanMar 2018Filed 19 AprJun 2018Filed 17 JulSep 2018Filed 8 OctDec 2018Filed 18 JanMar 2019Filed 12 AprJun 2019Filed 16 JulSep 2019Filed 18 OctDec 2019Filed 9 JanMar 2020Filed 22 AprJun 2020Filed 20 JulSep 2020Filed 19 OctDec 2020Filed 20 JanMar 2021Filed 10 AprJun 2021Filed 12 JulSep 2021Filed 21 OctDec 2021Filed 19 JanMar 2022Filed 14 AprJun 2022Filed 18 JulSep 2022Filed 21 OctDec 2022Filed 20 JanMar 2023Filed 18 AprJun 2023Filed 19 JulSep 2023Filed 17 OctDec 2023Filed 11 JanMar 2024Filed 16 AprJun 2024Filed 18 JulSep 2024Filed 18 OctDec 2024Filed 20 JanMar 2025Filed 16 AprJun 2025Filed 18 JulSep 2025Filed 14 OctDec 2025Filed 13 JanMar 2026Filed 15 AprJun 2026Filed 16 JulSep 2026Filed 19 Oct
GOVERNMENT PENSION FUND GLOBALForeign portfolio investors, category I––––––––––––––––––1.52%1.83%1.95%1.95%1.95%–––2.26%2.26%2.26%3.14%3.25%3.25%3.25%3.25%3.21%3.52%3.49%3.78%3.89%3.83%
AMANSA HOLDINGS PRIVATE LIMITEDForeign portfolio investors, category I––––––––––––––––––––––––––––––––––1.44%2.07%2.22%2.22%2.22%2.04%
SMALLCAP WORLD FUND, INCForeign portfolio investors, category I––––––––––––––––––––––––––4.52%4.84%4.84%3.47%3.13%3.10%3.38%3.21%2.11%2.01%––––
ASHISH DHAWANResident individuals, over ₹2 lakh at face value––––––––––––1.06%1.24%1.24%1.24%1.24%1.51%1.81%1.81%1.81%1.81%1.81%1.81%2.48%2.55%2.55%2.55%2.55%2.55%2.55%2.55%1.88%1.77%1.24%–––––
3P INDIA EQUITY FUND 1Alternative investment funds––––––––––––––––––––––––––––––––1.02%1.02%1.02%–––––
ELLIPSIS PARTNERS LLCForeign portfolio investors, category I–––––––––––––––––1.08%1.29%1.29%1.29%1.29%1.29%1.32%1.68%1.68%1.68%1.68%1.68%1.68%1.68%1.31%1.17%1.11%––––––
WGI EMERGING MARKETS SMALLER COMPANIES FUND, LLCForeign portfolio investors, category II–––––––––––––––––––––––––1.22%1.26%1.17%1.03%–––––––––––
LIFE INSURANCE CORPORATION OF INDIAInsurance companies2.03%1.31%––––––––––––1.75%1.81%1.81%–1.76%1.76%1.79%2.40%2.40%2.43%2.93%2.93%2.22%1.57%––––––––––––
NTASAIN DISCOVERY MASTER FUNDForeign portfolio investors, category II–––––––––––––––1.15%1.59%1.88%2.05%2.25%2.31%2.24%2.24%2.30%2.34%2.02%1.46%–––––––––––––
HSBC POOLED INVESTMENT FUND - HSBC POOLED ASIA PACForeign portfolio investors, category I–––––3.00%–––3.27%3.29%3.29%3.29%3.29%2.34%2.79%3.13%3.45%3.25%3.53%3.56%3.69%3.69%3.69%3.48%2.39%––––––––––––––
HSBC GLOBAL INVESTMENT FUNDS - ASIA EX JAPAN EQUITForeign portfolio investors, category I––––––––––––1.04%1.06%–1.16%1.44%1.78%1.32%1.47%1.58%1.64%1.64%1.55%1.04%–––––––––––––––
BAJAJ ALLIANZ LIFE INSURANCE COMPANY LTD.Other Institutions–––––––1.78%1.64%1.47%1.39%1.30%1.43%1.21%1.28%1.42%1.61%1.39%1.13%–––––––––––––––––––––
LIFE INSURANCE CORPORATION OF INDIA - ULIF00420091Other Institutions–––––––––––––––––1.76%––––––––––––––––––––––
HDFC LIFE INSURANCE COMPANY LIMITEDOther Institutions–––––––––––––1.28%1.28%1.28%1.28%1.24%––––––––––––––––––––––
LIC OF INDIA CHILD FORTUNE PLUS BALANCED FUNDFinancial Institution Or Banks–––––1.31%1.31%1.31%1.31%1.22%1.22%–1.75%1.75%––––––––––––––––––––––––––
FRANKLIN TEMPLETON INVESTMENT FUNDSInstitutions Foreign Portfolio Investor––1.19%1.74%–1.66%1.71%1.71%1.71%1.71%1.71%1.87%1.87%1.53%––––––––––––––––––––––––––
NTASIAN EMERGING LEADERS MASTER FUNDInstitutions Foreign Portfolio Investor–––––––––––––1.01%––––––––––––––––––––––––––
ARANDA INVESTMENTS (MAURITIUS) PTE LTDInstitutions Foreign Portfolio Investor3.99%3.99%3.99%3.99%3.99%3.99%3.99%3.99%3.54%2.88%2.76%2.76%1.30%–––––––––––––––––––––––––––
LIC OF INDIA MONEY PLUS GROWTH FUNDFinancial Institution Or Banks–––––––––––1.75%––––––––––––––––––––––––––––
NPS TRUST- A/C SBI PENSION FUND SCHEME - CENTRAL GOther non-institutions––––––––1.01%1.03%1.03%–––––––––––––––––––––––––––––
HSBC POOLED INVESTMENT FUNDInstitutions Foreign Portfolio Investor–––––––3.51%3.37%–––––––––––––––––––––––––––––––
WELLINGTON TRUST COMPANYInstitutions Foreign Portfolio Investor––––––1.24%1.09%––––––––––––––––––––––––––––––––
HSBC POOLED INVESTMENT FUND - HSBC POOLED ASIA PACIFIC EX JAPAN EQUITY FUNDInstitutions Foreign Portfolio Investor––1.25%1.78%––3.38%–––––––––––––––––––––––––––––––––
NEW HORIZON OPPORTUNITIES MASTER FUNDInstitutions Foreign Portfolio Investor1.42%1.42%1.42%1.42%1.42%1.42%––––––––––––––––––––––––––––––––––
HSBC POOLED INVESTMENT FUND - HSBC POOLED ASIAInstitutions Foreign Portfolio Investor––––2.48%–––––––––––––––––––––––––––––––––––
FRANKLIN TEMPLETON INVESTMENT FUNDInstitutions Foreign Portfolio Investor––––1.82%–––––––––––––––––––––––––––––––––––
LIC OF INDIAFinancial Institution Or Banks––1.31%1.31%1.31%–––––––––––––––––––––––––––––––––––
OPPENHEIMER DEVELOPING MARKETS FUNDInstitutions Foreign Portfolio Investor3.85%3.96%3.20%2.59%––––––––––––––––––––––––––––––––––––
T. ROWE PRICE EMERGING MARKETS STOCK FUNDInstitutions Foreign Portfolio Investor1.18%1.04%1.06%–––––––––––––––––––––––––––––––––––––
STICHTING DEPOSITARY APG EMERGING MARKETS EQUITY PInstitutions Foreign Portfolio Investor1.52%1.11%––––––––––––––––––––––––––––––––––––––
GOVERNMENT OF SINGAPOREInstitutions Foreign Portfolio Investor1.16%1.06%––––––––––––––––––––––––––––––––––––––
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.